United States companies developing new types of cortical INTEGRA electrode

United States INTEGRA life sciences companies developing new types of cortical electrode, the cortex Auragen electrode placed in the brain surface for safe and accurate detection of cortical EEG. Auragen for cortex EEG electrode is aimed at both before and after surgical removal of brain mapping program detection of epileptic foci. Electrode under different testing purposes can be placed in a cerebral cortical surface or insert subdural cavity surface contact cortex. Auragen cortex electrode with Platinum, Iridium, gold plated contacts, depending on surface area needs range from 4 to 64. Electrode cables connected to the records, which are also connected to the Hospital of EEG recording equipment. Electrodes can also be used to draw the preoperative tumor resection cortical function area, allowing doctors to avoid removal can cause paralysis or loss of language competence. Auragen electrode has been approved by the United States food and Drug Administration (FDA) approval and the CE mark certification in the EU, also receive the FDA on the magnetic resonance imaging (MRI) under the conditions of use. "Auragen electrode production through its increased conductivity, improved clear, consistent and reliable signals," INTEGRA's neuroscience marketing VP Christopher Feng Yao Branch said "our brain mapping electrodes and accessories progress reflects our commitment to the development of new products, enable clinicians to increase the confidence of detection. ”